The potency of TCR signaling can regulate the differentiation of naive CD4 ؉ T cells into Th1 and Th2 subsets. In this work we demonstrate that TCR signaling by low-affinity, but not high-affinity, peptide ligands selectively induces IL-4 transcription within 48 h of priming naive CD4 ؉ T cells. This early IL-4 transcription is STAT6 independent and occurs before an increase in GATA-3. Furthermore, the strength of the TCR signal differentially affects the balance of NFATp and NFATc DNA binding activity, thereby regulating IL-4 transcription. Low-potency TCR signals result in high levels of nuclear NFATc and low levels of NFATp, which are permissive for IL-4 transcription. These data provide a model for how the strength of TCR signaling can influence the generation of Th1 and Th2 cells.
A number of factors have been shown to influence the differentiation of naive CD4
ϩ T cells into either the Th1 or Th2 pathway, including cytokines, Ag dose, costimulation, and type of APC (1) (2) (3) (4) . In addition to Ag dose (5-7), the strength of the TCR interaction with the peptide/MHC complex can dramatically alter the differentiation process. In particular, peptides with a high affinity for the TCR favor the development of Th1 cells, whereas peptides with a low affinity for the TCR (altered peptide ligands (APLs) 4 ) preferentially induce the generation of Th2 cells (8 -11) . Biochemical analysis of the early signaling events immediately following TCR activation reveals an overall more transient pattern of early signaling with APL stimulation as compared with priming with an agonist peptide (12) . These events have been well studied in T cell clones as well as naive T cells. APL-induced signaling is characterized by unsaturated forms of phospho-CD3-chain, a lack of phosphorylation of ZAP70, linker for activation of T cells, and phospholipase C-␥1 and a weak, transient pattern of calcium mobilization, while agonist peptides induce a full and sustained pattern of signaling (13) (14) (15) (16) .
Although weak, transient TCR signals correlate with the development of Th2 cells, recent studies suggest that weak signaling per se is not sufficient for Th2 differentiation, but rather a specific signaling component is required. For example, mice deficient in CD4, lck, or Itk fail to develop normal Th2 responses in vitro and in vivo (17) (18) (19) (20) (21) (22) . The failure to observe Th2 differentiation in these cases correlates with decreased calcium flux. In terms of CD4 signaling, this is especially evident during low potency signaling where CD4 coreceptor function is more important for TCR-mediated signal transduction (19) . Together, these data suggest that the level of calcium mobilization provides an important signal to initiate the development of Th2 cells.
Although these studies have added significantly to our understanding of Th cell differentiation, it remains to be determined how these early signaling events (within minutes of TCR signaling) translate into discrete, cytokine-secreting effector populations (6 -7 days after priming). One approach is to study the lineage-specific cytokine genes and their associated transcription factors and determine how they might be regulated by specific TCR signals. Multiple factors have been identified that appear to regulate IL-4 production and are preferentially associated with Th2 differentiation, including GATA-3, STAT6, and c-maf (23, 24) . Overexpression of either STAT6, GATA-3, or c-maf leads to the induction of Th2 cytokines in developing Th1 cells, suggesting a key role for each in Th2 cytokine regulation (25) (26) (27) . Engagement of the IL-4R by IL-4 leads to the activation of STAT6 and the subsequent upregulation of GATA-3 (28) . Increased GATA-3 expression correlates with commitment to the Th2 pathway and is observed by 48 h after priming CD4 ϩ T cells (26, 29) . In contrast, c-maf appears to be a relatively late activator of IL-4 transcription because its expression is not up-regulated until 5-7 days after priming (30) . While these transcription factors are clearly important for generating Th2 cells, their activation and up-regulation appear to be primarily cytokine driven and not TCR driven.
Transcription factors that might be regulated by the strength of TCR signaling and are implicated in the expression of several cytokine genes are the NFATs. NFAT target sequences have been identified in the promoters of multiple cytokine genes, including IL-2, IL-4, IL-3, GM-CSF, and TNF-␣ (31) . Several studies have demonstrated a crucial role for NFATc (NFATc1 or NFAT2), NFATp (NFATc2 or NFAT1), and NFAT4 (NFATc3) in the regulation of Th1 and Th2 cytokine gene transcription. NFATc-deficient mice exhibit a selective decrease in IL-4 production and impaired IgG1 and IgE production, suggesting a positive role for NFATc in the regulation of IL-4 responses (32, 33) . In contrast, mice deficient in NFATp (34 -36) display a modest increase in Th2 development, which is greatly accentuated in mice deficient in NFAT4 as well (37) . The increase in IL-4 production in these mice Departments of *Immunobiology and † Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520 has been attributed to unopposed NFATc activity and suggests that NFATp and/or NFAT4 may function to down modulate or inhibit IL-4 transcription. Although these findings are important to our understanding of the factors involved during Th2 differentiation, they all involve the use of KO mice and thus do not address the issue of how these signals emerge during the priming of a naive CD4 ϩ T cell. Because the NFATs are exquisitely regulated by the level of calcium mobilization within a cell (38, 39) , we postulated that this may provide a mechanism by which the strength of TCR signaling may regulate the development of Th1 and Th2 effector cells. Ag stimulation through the TCR triggers the release of intracellular calcium and the subsequent activation of calcineurin (40, 41) . Calcineurin dephosphorylates cytoplasmic NFAT family members, allowing their nuclear translocation where they cooperatively bind their target sequences together with AP-1 proteins and initiate transcription (42) . The export of NFATs from the nucleus is equally sensitive to the changes in calcium concentration such that a drop in calcium levels causes the proteins to become rephosphorylated and shuttled back to the cytoplasm (43, 44) . Consequently, the degree of calcium mobilization initiated by TCR signaling may affect NFAT translocation and, in turn, NFAT-dependent gene transcription.
In this paper we demonstrate that the strength of TCR signaling in naive CD4
ϩ T cells differentially regulates the nuclear translocation of NFAT family members. By modulating the potency of TCR signaling with an APL, we can alter the relative ratio of NFATp and NFATc localization in the nucleus and regulate the transcription of IL-4 message within 48 h of naive T cell priming. The induction of IL-4 transcription in this system is independent of STAT6 signaling and occurs before an increase in GATA-3 expression, which is STAT6 dependent. In contrast, stimulation with a strong agonist peptide increases the NFATp binding activity and down-regulates GATA-3 expression, thus inhibiting early IL-4 transcription. These data provide a model for how the potency of TCR signaling can influence the generation of Th1 and Th2 cells.
Materials and Methods

Mice
The TCR-transgenic mice in which CD4 ϩ T cells express a TCR specific for moth cytochrome c peptide (MCC) in the context of I-E k or I-E b have been previously described (45) . These mice were bred in our facilities and maintained as heterozygotes on a B10.A (5R), B10.BR, or C57BL/6 (B6) background. STAT6 Ϫ/Ϫ mice on a B6/129 background (46) were generously provided by J. Ihle (St. Jude's Research Center, Memphis, TN) and backcrossed onto a B6 TCR ϩ/Ϫ background to generate homozygous STAT6 Ϫ/Ϫ and heterozygous TCR ϩ/Ϫ mice. B10.A (5R) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and bred in our facility. All TCR mice used in these studies were 6 -8 wk old.
Peptides
MCC (81-103) and its APL, K99R, were synthesized by the W. M. Keck Foundation Biotechnology Resource Laboratory (New Haven, CT). The sequence of the MCC peptide is VFAGLKKANERADLIAYLKQATK and the sequence of the K99R peptide is VFAGLKKANERADLIAYLRQATK.
Preparation of APCs and CD4
ϩ T cells T cell-depleted APC were prepared by Ab-mediated complement lysis of B10.A (5R) splenocytes as previously described (47) . The APC were treated with 50 g/ml mitomycin C (Sigma-Aldrich, St. Louis, MO) before use. CD4 ϩ T cells from lymph nodes and spleens of TCR-transgenic mice were isolated by immunomagnetic negative selection (47) using Abs against CD8, CD32/CD16, B220, MHC class II, and NK cells, followed by incubation with anti-mouse and anti-rat Ig-coated magnetic beads (Polysciences, Warrington, PA). Purity of the recovered V␣11 ϩ CD4 ϩ T cells was 85-95% as determined by staining with anti-CD4 and anti-V␣11 mAbs. Naive CD4 ϩ T cells were obtained from this population by sorting for Pgp-1 low and Mel14 high cells using a FACSVantage SE cell sorter (BD Bioscences, Mountain View, CA). The resultant population was 99% pure for both Mel14 high and Pgp-1 low . Equivalent results were obtained using either total CD4 ϩ T cells or FACS sorted, naive CD4 ϩ T cells.
In vitro stimulation of TCR-transgenic CD4 ϩ T cells
Induction of naive T cell differentiation was performed as previously described (10), with slight modifications. Briefly, mitomycin C-treated APC (1 ϫ 10 6 /ml) were incubated with CD4 ϩ T cells (5 ϫ 10 5 /ml) from TCRtransgenic mice, peptide (MCC at 5 g/ml or K99R at 10 -15 g/ml), rIL-2 (25 U/ml), and anti-IFN-␥ Ab. When stimulating TCR-transgenic CD4 ϩ T cells from the B10.BR background, peptide-primed APC were used by incubating APC with 50 M APL or agonist peptide for 3 h at 37°C, followed by three washes. rIL-2 and anti-IFN-␥ Ab were also included in the primary culture. After 4 days of priming, T cells were harvested and dead cells were removed by gradient centrifugation. Viable T cells were then incubated for a rest period of 2 days. For secondary culture, rested T cells (5 ϫ 10 5 /ml) were restimulated with fresh APC (1 ϫ 10 6 /ml) and 5 g/ml MCC peptide for an additional 2-day period, after which supernatants were collected for cytokine analysis. The presence of IL-4 and IFN-␥ in the supernatants was determined using ELISA kits from Endogen (Cambridge, MA). Calculated values are expressed as means Ϯ SEM. In some experiments, cyclosporin A (CsA) or ionomycin (Calbiochem, San Diego, CA) was added during the primary culture. For CsA, T cells were preincubated with the drug for 30 min at 37°C at the indicated concentrations (12.5-25 ng/ml) before the addition of APCs and peptide. Ionomycin (10 -100 nM) was added to the T cells at the same time as the APCs and peptide.
RNA analysis of primary transcripts
After 2 days in the primary culture, cells were harvested and dead cells were removed by gradient centrifugation. Total cellular RNA was isolated using TRIzol reagent (Life Technologies, Frederick, MD). Cytokine RNA levels were analyzed by RNase protection assay (RPA) using the RiboQuant multiprobe kit with the mCK-1 template (BD PharMingen, San Diego, CA). Five micrograms of total RNA was used in each reaction. To ensure equal loading, transcript levels for two housekeeping genes (L32 and GAPDH) were quantified for each sample with a GS-525 Molecular Imager System and Molecular Analyst software (Bio-Rad, Hercules, CA). For Northern blot analysis, 10 g of total RNA from each sample was fractionated on 1.2% agarose/formaldehyde gels, transferred to -Probe GT membranes (Bio-Rad), and hybridized with the indicated cDNA probes in QuikHyb buffer (Stratagene, La Jolla, CA). The GATA-3 cDNA probe was a 460-bp HindIII-SacI fragment derived from pBS-GATA3 construct kindly provided by R. Flavell (Yale University, New Haven, CT). The mouse GAPDH and 18S rRNA cDNA probes were purchased from Ambion (Austin, TX) and were used to monitor total RNA loading of each sample. UV shadowing of the membrane to visualize 28S and 18S ribosomal RNA (rRNA) was also performed to ensure equivalent sample loading.
Calcium mobilization
Calcium signaling following Ag-specific stimulation was monitored as described previously (48) . Briefly, CD4
ϩ T cells loaded with 5 M fluo-3/AM ester (Molecular Probes, Eugene, OR) were plated by centrifugation in 96-well plates at a concentration of 5 ϫ 10 5 cells/50 l. The cells were then scanned using the ACAS 570 video laser cytometer (Meridian Instruments, Okemos, IL). After initiation of scanning, 4 ϫ 10 6 T-depleted splenocytes, pulsed with 20 M peptide, were added to the CD4 ϩ T cells. The initial average fluorescence of each cell was digitized and normalized to 1, and the results are expressed as changes in normalized fluorescence intensity of individual cells over time. The percentage of responding cells was determined by dividing the number of cells demonstrating an increase in intracellular calcium of Ͼ50% by the total number of scanned cells.
Preparation of nuclear extracts
CD4
ϩ T cells were stimulated with peptide and APC for 48 h, as described above. Viable cells were collected by gradient centrifugation. After washing in cold PBS, the cell pellet was resuspended in 250 l buffer A (10 mM HEPES (pH 7.9), 3 mM MgCl 2 , 10 mM NaCl, 0.1 mM EDTA, 300 mM sucrose, 0.5 mM DTT, and a mixture of protease inhibitors) and incubated on ice for 10 min. Next, 25 l of 1% Nonidet P-40 solution was added and mixed carefully. Cells were immediately centrifuged at 800 ϫ g for 1 min. The nuclear pellet was washed in 200 l of buffer A and centrifuged again at 800 ϫ g for 1 min. Pelleted nuclei were resuspended in 50 l of buffer B (20 mM HEPES (pH 7.9), 3 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT, and a mixture of protease inhibitors) and incubated on ice for 15 min. The suspension was vortexed briefly and centrifuged at 16,000 ϫ g for 5 min. Supernatants were stored at Ϫ70°C and protein concentrations were determined using the BCA Protein Assay kit from Pierce (Rockford, IL).
EMSA
EMSAs for NFATs were performed with 3 g of nuclear extract incubated with 1 g of poly(dI:dC) in 20 l of 1ϫ binding buffer (10 mM HEPES (pH 7.9), 50 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 10% glycerol, 0.1% Nonidet P-40, 0.5 mg/ml BSA, 1 mM benzamidine, and 1 mM DTT) with 7.5 ϫ 10 5 cpm of a 32 P-labeled probe for 20 min at room temperature. Complexes were resolved on nondenaturing 6% polyacrylamide gels (37.5:1 cross-linking ratio) in 0.5ϫ TBE for 2.5 h at 140 volts. For supershift reactions, nuclear extracts were preincubated for 15 min on ice with the appropriate Abs before the addition of the labeled probe. For detection of NFAT binding, a double-stranded oligonucleotide from the murine IL-4 promoter (Ϫ88 to Ϫ60) was used: 5Ј-CTGGTGTAATAAAATTTTCCA ATGTAAAC-3Ј. The supershifting Abs for NFATp (clone 4G6-G5) and NFATc (clone 7A6) were from Santa Cruz Biotechnology (Santa Cruz, CA). NF-B EMSAs were performed with 5 g of nuclear extract incubated with 2 g of poly(dI:dC) in 20 l of 1ϫ binding buffer (10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA, 5% glycerol, 1 mg/ml BSA, 3 mM GTP, 1 mM benzamidine, and 1 mM DTT) with 5 ϫ 10 5 cpm of a 32 P-labeled probe for 30 min at room temperature. Complexes were resolved on nondenaturing 6% polyacrylamide gels (29:1 cross-linking ratio) in 0.5ϫ TBE for 2.5 h at 140 volts. The sequence for the NF-B probe (derived from the murine intronic enhancer) is 5Ј-GATCAGAGGGGACTTTCCGAGG-3Ј.
Results
TCR/peptide affinity regulates early IL-4 transcription
Using an in vitro system for T cell differentiation with TCR-transgenic CD4
ϩ T cells, we have previously shown that altering the affinity of the peptide/MHC ligand can selectively induce Th1 or Th2 differentiation. Priming with the agonist peptide (MCC), i.e., a strong TCR signal, generates Th1 cells (10) . In contrast, an APL (K99R), which lowers the TCR affinity for the antigenic complex by ϳ300-fold but does not change the affinity of binding to MHC class II (49) , induces predominantly Th2 differentiation with a low level of Th1 differentiation (10) . This observation is best illustrated by cytokine production upon restimulation of the primed CD4 ϩ T cells with the agonist peptide. As shown in Fig. 1A, CD4 ϩ T cells primed initially with MCC differentiated into IFN-␥-producing or Th1 effector cells. In contrast, priming with K99R generated predominantly IL-4-secreting or Th2 effector cells.
To better understand how the strength of the TCR signal promotes this selective skewing of primary T cells, we performed RPAs to examine cytokine transcriptional events at day 2 of priming, when commitment to either pathway in the presence of skewing cytokines has been observed (50) . Priming naive CD4 ϩ T cells with the agonist peptide for 48 h leads to strong induction of IL-2 transcription (Fig. 1B) . In striking contrast, priming with K99R primarily induces transcription of the Th2 cytokines, IL-4, IL-13, and IL-9. Phosphor imaging analysis from five independent experiments clearly demonstrates IL-4 induction is specific to stimulation with K99R (Fig. 1C, upper panel) and represents a 3-to 6-fold increase over MCC (Fig. 1C, lower panel) . The reduced IL-2 transcription in the APL cultures, compared with agonist cultures, agrees with previous findings in T cell clones that APLs are poor initiators of IL-2 production (51-53). As shown in Fig. 1D , GATA-3 mRNA levels correlate with the level of IL-4 transcription such that GATA-3 message is only up-regulated in the presence of a low-affinity TCR signal. ϩ T cells from AND TCR-transgenic mice were primed in vitro with either agonist peptide (MCC) or APL (K99R) with APC for 4 days, then washed and rested, as described in Materials and Methods. Equivalent numbers of CD4 ϩ T cells from each group were restimulated for 2 days with fresh APC and 5 g/ml agonist peptide and the supernatants were analyzed for IL-4 and IFN-␥ by ELISA. B, Naive CD4 ϩ T cells were primed as in A but only for 48 h. Total cellular RNA from viable cells was analyzed by RPA using the mCK-1 probe from BD PharMingen. Shown are cytokine transcript levels after an overnight exposure and housekeeping transcripts (L32 and GAPDH) after a 2-h exposure to confirm equivalent RNA loading. C, Fold induction of IL-4 message levels for MCC and K99R from five independent experiments. IL-4 transcript levels from RPA analysis were quantified by phosphor imaging, normalized to expression of the housekeeping gene GAPDH, and divided by the background to yield a fold induction over background (upper panel). Therefore, a fold induction of 1 represents background levels, or no significant expression. Due to variations between experiments, IL-4 transcript levels were also compared as a ratio between K99R and MCC for each experiment (lower panel). D, Ten micrograms of total RNA from 48-h cultures primed with MCC or K99R was subjected to Northern blot analysis and probed for GATA-3 and 18S rRNA. The first lane represents 10 g of total RNA from unprimed CD4 ϩ T cells. The relative amounts of GATA-3 were quantified by densitometric analysis and divided by the relative amounts of 18S rRNA to normalize for differences in loading (lower panel).
To determine whether the early IL-4 transcription observed with the APL was actually due to TCR signaling differences, STAT6-deficient CD4 ϩ T cells were stimulated with K99R to exclude IL-4 signaling from exogenous sources. Importantly, CD4
ϩ T cells primed with K99R transcribe IL-4 in the absence of STAT6 (Fig.  2A, lane 2) . While the induction of IL-4 is reduced compared with that seen with wild-type (WT) CD4 ϩ T cells, it is clearly specific for the APL and represents a nearly 3-fold increase over background (Fig. 2B) . Similarly, WT CD4 ϩ T cells primed with K99R, in the presence of anti-IL-4 Ab to also prevent signaling through the IL-4R, transcribed IL-4 message at a level comparable to the STAT6-deficient cells (Fig. 2, A and B) . Of note, IL-4 transcription under these circumstances occurs without an increase in the basal level of GATA-3 expression (Fig. 2C) , indicating that increased levels of GATA-3 are dependent upon STAT6 signaling but are not absolutely required to induce low levels of IL-4. As cells become fully committed to the Th1 pathway, GATA-3 expression becomes down-regulated, as seen when STAT6-deficient cells are primed with a high-affinity TCR signal (Fig. 2C, lane 3 , and data not shown). These data suggest that the small amount of GATA-3 present in naive CD4 ϩ T cells is sufficient to promote low levels of IL-4 transcription. Moreover, they strongly argue that the TCR signal itself, and not responsiveness to exogenous IL-4, induces the initial IL-4 expression.
Differential calcium mobilization induced by APL
We next asked what about the TCR signaling pattern is different between agonist and APL that might preferentially induce IL-4 transcription when a weak signal is given to a naive CD4 ϩ T cell. One of the fundamental differences previously observed in early TCR signaling events is the magnitude and pattern of calcium mobilization (15, 16, 54) . Analysis of intracellular calcium flux in individual T cells following TCR engagement with the two different peptides is shown in Fig. 3 . The agonist peptide induces a strong, sustained calcium flux from the majority of responding cells. In striking contrast, K99R induces a weak and often transient calcium flux. As seen in Fig. 3C , the number of responding cells is greatly diminished during low-affinity peptide stimulation compared with stimulation with a high-affinity ligand (ϳ25% for K99R vs ϳ50% for MCC, Fig. 3C ). In addition, most of the MCC-responding cells (ϳ90%) showed a sustained calcium flux lasting Ͼ5 min, whereas the cells responding to K99R exhibited a mixed pattern of calcium mobilization (Fig. 3D) . Within the population of APL-stimulated cells that generated a sustained calcium flux, the pattern of calcium mobilization was often shorter in duration than seen within the MCC-stimulated cells (compare the lower single cell tracings in Fig. 3B ).
Whereas the potency of TCR signaling clearly regulates the pattern of calcium mobilization, these data do not indicate whether the transient calcium flux induced by the APL is important for the initiation of IL-4 transcription in naive CD4
ϩ T cells and commitment to the Th2 pathway. To address this issue, we examined the effect of CsA during priming with the APL. Treatment of CD4 ϩ T cells with low doses of CsA to inhibit the calcium/calcineurin pathway during priming clearly blocks IL-4 transcription normally seen during APL stimulation (Fig. 4A ) and subsequently inhibits Th2 differentiation (Fig. 4C) . These data suggest that the transient calcium flux observed following APL stimulation is an important component of biochemical signals leading to the development of Th2 cells.
Because the agonist peptide induces a strong, sustained calcium flux, we postulated that treatment of APL-stimulated cells with a calcium ionophore to create a sustained increase in intracellular calcium would inhibit early IL-4 transcription and promote Th1 differentiation. Fig. 4 , B and D, demonstrate that the presence of ionomycin during APL stimulation inhibits IL-4 transcription as well as Th2 differentiation. Furthermore, the decrease in IL-4 transcription leads to an increase in Th1 development as observed by the dramatic increase in IFN-␥-producing cells (Fig. 4D) , analogous to stimulation with an agonist peptide. These findings provide support for our earlier observation that the generation of Th2 cells by APL stimulation is sensitive to both CsA and ionomycin (16) and extend those analyses to demonstrate a direct effect on early transcriptional events during priming of naive CD4 ϩ T cells. Together, these and published data suggest that a weak or transient pattern of calcium signaling is important for the induction of early IL-4 transcription and subsequent Th2 differentiation.
FIGURE 2. Early IL-4 transcription is TCR dependent and STAT6 independent. STAT6 WT or STAT6-deficient (KO) CD4
ϩ T cells were primed with APL (K) or agonist peptide (M) in the absence or presence of anti-IL-4 Ab for 48 h. Total RNA from these cultures was analyzed by RPA (A) and quantified by phosphor imaging analysis for IL-4 transcript levels (B), as described in Fig. 1 . C, Total RNA from above was subjected to Northern blot analysis and probed for GATA-3 and GAPDH. Data are representative of three independent experiments.
Low-potency TCR signals alter the NFATc/p ratio
Calcium signaling is an extremely important regulator of NFAT family members such as NFATc and NFATp, which are two factors predicted to have opposing roles in the regulation of IL-4 expression. As such, we asked whether the distinct patterns in calcium mobilization observed with the two peptides corresponded to a difference in specific NFAT DNA binding activity. As demonstrated in Fig. 5A , there is a notable difference in NFATp vs NFATc DNA binding activity, depending on the potency of the TCR signal. A strong TCR signal (MCC) correlates with abundant NFATp and NFATc binding. In contrast, a weak TCR signal (K99R) results in poor NFATp but significant NFATc levels, indicating a differential sensitivity of the two proteins to calcium/ calcineurin activation. Of note, the differences in NFAT binding activity correlated with the nuclear localization of NFATc and NFATp, as determined by Western blot analysis of nuclear fractions (data not shown). NF-B, which is regulated, in part, by the calcium/calcineurin pathway but also by protein kinase C, demonstrated fairly similar levels of DNA binding activity, indicating the strength of the TCR signal did not have a significant effect on its activity (Fig. 5B) . Densitometric analyses of the relative amounts of nuclear NFAT indicate that priming with an agonist peptide yields at least a 2-fold increase in the amount of NFATp relative to APL-primed cells, while NFATc activity is more similar between the two priming conditions (Fig. 5C, left panel) . Furthermore, a comparison of the ratio of NFATc/NFATp binding activity from three independent experiments revealed an extremely reproducible ratio ( p ϭ 0.02) for the two priming conditions (Fig. 5C,  right panel) . MCC-primed T cells typically have a 1.8:1 ratio of NFATc:NFATp, whereas K99R induces a ratio of 3.8:1. The significance of these findings is underscored by reports of NFAT knockout mice that predict a positive role for NFATc and a negative role for NFATp in the regulation of IL-4 transcription. As such, our data predict that the strength of the TCR signal can influence the balance of the two NFAT proteins and thus affect Th differentiation.
To assess the role of NFATc and NFATp in regulating IL-4 transcription in our system, NFAT activity was measured during APL stimulation, in the presence of CsA or ionomycin. Fig. 6A demonstrates that NFAT DNA binding activity during APL priming is extremely sensitive to CsA, likely due to the predicted low level of calcineurin activity associated with a transient calcium flux. At the lowest dose of CsA, NFATp and nearly all NFATc DNA binding activity is inhibited. Of note, NF-B nuclear translocation is unaffected by these low doses of CsA. In contrast, treatment with ionomycin during priming with APL leads to an increase in the amount of both NFATp and NFATc activity at the higher dose of ionomycin, which mimics the pattern of agonist peptide signaling (Fig. 6B) . In fact, densitometric analysis of the levels of NFATc vs NFATp clearly demonstrates a dose-dependent switch in the ratio of NFATc/NFATp ( Fig. 6C ; 3.5:1 without ionomycin and 1.7:1 with 100 nM ionomycin). Similar treatment with ionomycin during MCC priming clearly has no effect on the NFATc/p ratio even though ionomycin promotes additional NFAT translocation (Fig. 6D) .
The changes in the relative amounts of NFATp and NFATc DNA binding activity in the nucleus upon CsA or ionomycin treatment of APL-stimulated cells are mirrored in their effect on IL-4 transcription and Th2 differentiation, as shown in Fig. 4 . Together, these data indicate that pharmacologically mediated changes in calcineurin/NFAT signaling can alter the nuclear localization of NFATs toward a ratio of NFATc/p that will inhibit early IL-4 transcription. Moreover, they provide a mechanistic basis for how the strength of the TCR signal can regulate the balance of NFAT family members to a ratio that is permissive for IL-4 transcription and Th2 differentiation. As such, our data provide evidence for the hypothesis that the balance between NFAT family members is crucial to the differentiation of naive CD4 ϩ T cells.
Discussion
The strength of the TCR signal can regulate naive T cell differentiation into distinct effector cell subsets. High-potency signals promote Th1 differentiation while low potency signals promote Th2 differentiation. In this report, we demonstrate that specific signals generated through the TCR by an APL are sufficient to induce IL-4 transcription in naive CD4 ϩ T cells within 48 h of priming. IL-4 production in this system is independent of STAT6 and occurs before an increase in the basal level of GATA-3 present in naive CD4 ϩ T cells. Furthermore, we find that the strength of TCR signal received during priming affects the degree of NFATp and NFATc localization to the nucleus. Strong signals increase NFATp nuclear localization, which correlates with poor Th2 differentiation and robust Th1 differentiation. In contrast, weaker TCR signals result in low levels of nuclear NFATp but maintain significant amounts of nuclear NFATc to promote early IL-4 transcription and subsequent Th2 differentiation.
Because the vast majority of studies looking at the regulation of Th cell commitment use cytokine skewing to generate Th1 and ϩ T cells, stimulated with MCC or K99R and APC for 48 h, were subjected to EMSA using a NFAT probe from the murine IL-4 promoter. The specificity of binding was determined with supershifting Abs for NFATp or NFATc. Open arrowheads indicate shifted DNA/protein complexes containing either NFATp or NFATc. The filled arrowhead points to the supershifted complexes containing the indicated NFAT Ab. B, Gel-shift analysis of nuclear fractions from MCC-or K99R-primed CD4 ϩ T cells was performed with a probe specific for NF-B. C, The amount of specific NFAT binding activity (from the supershifted complexes) was quantified by densitometry and averaged from three independent experiments. The average ratio of NFATc to NFATp DNA binding activity for MCC or K99R stimulations was also determined and the significance was calculated using the Student's t test (p ϭ 0.02). Th2 cells, our finding that an APL selectively induces IL-4 transcription within 48 h of priming a naive CD4
ϩ T cell provides a critical tool for further studying the regulation of Th cell differentiation. Importantly, the induction of early IL-4 transcription is dependent on the strength of the TCR signal but independent of signaling through the IL-4R/STAT6 complex, which highlights several important points.
First, an exogenous source of IL-4 is not required to initiate IL-4 transcription in a naive CD4 ϩ T cell and thus is not dependent upon STAT6 signaling. Several groups have found that STAT6-deficient mice are unable to generate Th2 inflammatory responses and are profoundly impaired in generating IL-4-secreting effector cells in vivo and in vitro (46, 55, 56) . However, these studies were analyzing late events in the generation of Th2 responses such as cytokine production upon restimulation and IgE production. Our analysis within 48 h of priming a CD4 ϩ T cell with an APL indicates STAT6 is not an early mediator of IL-4 transcription because we can block IL-4R signaling by using either STAT6-deficient CD4
ϩ T cells or anti-IL-4 Abs and still detect IL-4 message. This finding agrees with other recent reports showing that IL-4 can be made in the absence of STAT6 signaling (57) (58) (59) (60) . Importantly, though, STAT6 is clearly necessary for the up-regulation of GATA-3 and the generation and expansion of IL-4-secreting Th2 effector populations in our system (data not shown).
Second, the potency of the TCR signal provides specific signals that are necessary to initiate early IL-4 transcription. We and others have previously found that weak TCR signals preferentially induce Th2 development while strong TCR signals promote Th1 differentiation (61) . Moreover, it has become evident that weak signals alone are not enough to generate Th2 cells but that a specific signaling event is required and is linked to calcium signaling in that only a weak, transient pattern of calcium mobilization correlates with Th2 development. This idea initially arose from the finding that CsA treatment of naive CD4 ϩ T cells during priming with an APL inhibited Th2 but not Th1 differentiation (16) . Further support for calcium providing an important signal for Th2 differentiation came from mice deficient in CD4, lck, or Itk. In all cases, Th2 development was severely impaired and correlated with a decreased calcium flux (17) (18) (19) (20) (21) (22) . However, increasing the level of calcium mobilization induced by an APL with ionomycin, so as to mimic an agonist peptide or sustained calcium signaling, led to inhibition of early IL-4 transcription, suggesting that the potency of the calcium signal can differentially regulate IL-4 transcription.
Our ability to alter early IL-4 transcription by manipulating the calcium/calcineurin/NFAT pathway with pharmacological reagents highlights the importance of this pathway during Th cell differentiation. Inhibition of NFAT activation by CsA during APL priming results in an inhibition of IL-4 transcription, supporting the well-accepted notion that IL-4 transcription is NFAT dependent. Together, these data strongly imply that a certain threshold of calcium signaling is necessary for the initiation of IL-4 transcription but that strong calcium signals such as those induced by an agonist peptide can inhibit IL-4 transcription and Th2 differentiation. This kind of model can be explained by the differential regulation of NFATc/p translocation based on the potency of the TCR signal. While a weak TCR signal imparts selective NFATc nuclear translocation and IL-4 transcription, a strong TCR signal promotes both NFATc and NFATp nuclear translocation but fails to induce IL-4 transcription. Similarly, ionomycin treatment during APL stimulation inhibited IL-4 transcription and correlated with an increase in nuclear NFATp. The significance of these observations is underscored by the fact that high levels of nuclear NFATc are not simply sufficient to induce IL-4 but the absence or low level of NFATp is also required. For example, stimulation with an agonist peptide induces both NFATc and NFATp translocation but does not induce IL-4 transcription. These data are consistent with the NFATp-deficient mouse models, which suggested a negative role for NFATp in the regulation of IL-4 (35, 36) . In these studies, priming CD4 ϩ T cells in the absence of NFATp led to an accumulation of IL-4 message by 48 h.
In contrast to the inhibitory role for NFATp, NFATc is thought to be a positive regulator of IL-4 transcription given that NFATcdeficient T cells are impaired in their ability to make IL-4 or differentiate into Th2 cells (32, 33) . In support of this idea, doses of CsA that prevented nuclear translocation of NFATc during priming with APL correlated with a lack of IL-4 transcription. Because calcineurin can also regulate the activity of NF-B and c-Jun Nterminal kinase (JNK) (62) (63) (64) , the CsA-mediated effects on early IL-4 message may be due to indirect effects on these two pathways, though the likelihood of such seems rather limited. Whereas NFAT activation absolutely requires a calcium stimulus, NF-B and JNK are only partially dependent upon a calcium signal and can be activated via other pathways (62, 65, 66) . Analysis of NF-B activation indicated that the strength of TCR signal did not have a differential effect on its nuclear localization in that agonistand APL-primed cells expressed similar levels of p65 and p50 in the nucleus at 48 h. In addition, the low doses of CsA used in this study did not inhibit NF-B translocation in our system. Consistent with these findings, Dolmetsch et al. (39) demonstrated that NFATc/p nuclear translocation is more sensitive to calcium signals than NF-B and JNK activation.
There are a number of circumstances during naive T cell priming in which there is no preexisting cytokine microenvironment (2) . Under these conditions, we propose that the strength of the TCR signal becomes extremely important in regulating the balance between the development of Th1 and Th2 cells. In this study, we find that the potency of the TCR signal differentially regulates the nuclear translocation of NFATc and NFATp and, in turn, influences cytokine gene transcription. These findings suggest a model in which differences in TCR-mediated signals affect the relative balance of different NFAT family members to either promote or inhibit a low level of IL-4 gene transcription. After high-potency stimulation, early IL-4 transcription and Th2 differentiation are inhibited due to high levels of NFATp and low levels of GATA-3 expression. In contrast, stimulation with low-potency ligands induces less NFATp but sufficient NFATc levels in the nucleus to promote IL-4 transcription. This small amount of IL-4 feeds back through the IL-4R to activate STAT6 and up-regulate GATA-3 expression, which enable the full development of Th2 effector cells.
